close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,008.12

+1.46%↑

JNJ

209.41

+2.16%↑

ABBV

222.68

-1.08%↓

UNH

336.6

+2.73%↑

AZN

90.64

-0.59%↓

LLY

1,008.12

+1.46%↑

JNJ

209.41

+2.16%↑

ABBV

222.68

-1.08%↓

UNH

336.6

+2.73%↑

AZN

90.64

-0.59%↓

LLY

1,008.12

+1.46%↑

JNJ

209.41

+2.16%↑

ABBV

222.68

-1.08%↓

UNH

336.6

+2.73%↑

AZN

90.64

-0.59%↓

LLY

1,008.12

+1.46%↑

JNJ

209.41

+2.16%↑

ABBV

222.68

-1.08%↓

UNH

336.6

+2.73%↑

AZN

90.64

-0.59%↓

LLY

1,008.12

+1.46%↑

JNJ

209.41

+2.16%↑

ABBV

222.68

-1.08%↓

UNH

336.6

+2.73%↑

AZN

90.64

-0.59%↓

Home・Aandelen Lijst・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Open

SectorGezondheidszorg

2.16 -1.37

Buy

Prijsupdate 11 dec 2025, 19:36 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

2.13

Max

2.21

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+236.24% upside

Nieuwssentiment

By Acuity

50%

50%

195 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

1.76 / 1.94 Steun & Weerstand

Inovio Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

10 dec 2025, 22:02 UTC

Winsten

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

DJ

Lezen

10 dec 2025, 21:46 UTC

Winsten

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

DJ

Lezen

10 dec 2025, 23:52 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

DJ

Lezen

10 dec 2025, 23:43 UTC

Marktinformatie

Nikkei May Rise After Fed Rate Cut -- Market Talk

DJ

Lezen

10 dec 2025, 23:36 UTC

Marktinformatie

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

DJ

Lezen

10 dec 2025, 23:20 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

DJ

Lezen

10 dec 2025, 23:15 UTC

Winsten

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

DJ

Lezen

10 dec 2025, 22:59 UTC

Marktinformatie
Winsten
Acquisities, Fusies, Overnames

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

DJ

Lezen

10 dec 2025, 22:45 UTC

Marktinformatie

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

DJ

Lezen

10 dec 2025, 22:40 UTC

Winsten

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

DJ

Lezen

10 dec 2025, 22:06 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

DJ

Lezen

10 dec 2025, 22:06 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

DJ

Lezen

10 dec 2025, 22:02 UTC

Winsten

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

DJ

Lezen

10 dec 2025, 22:00 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

DJ

Lezen

10 dec 2025, 21:53 UTC

Winsten

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

DJ

Lezen

10 dec 2025, 21:50 UTC

Acquisities, Fusies, Overnames

Investors Bet That a Higher Bid for Warner Is Coming -- Update

DJ

Lezen

10 dec 2025, 21:50 UTC

Marktinformatie
Winsten
Acquisities, Fusies, Overnames

Financial Services Roundup: Market Talk

DJ

Lezen

10 dec 2025, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

10 dec 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

10 dec 2025, 21:45 UTC

Acquisities, Fusies, Overnames

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

DJ

Lezen

10 dec 2025, 21:33 UTC

Winsten

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

DJ

Lezen

10 dec 2025, 21:32 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

DJ

Lezen

10 dec 2025, 21:28 UTC

Acquisities, Fusies, Overnames

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

DJ

Lezen

10 dec 2025, 21:25 UTC

Winsten

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

DJ

Lezen

10 dec 2025, 21:18 UTC

Acquisities, Fusies, Overnames

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

DJ

Lezen

10 dec 2025, 21:16 UTC

Winsten

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

DJ

Lezen

10 dec 2025, 21:15 UTC

Acquisities, Fusies, Overnames

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

DJ

Lezen

10 dec 2025, 21:15 UTC

Winsten

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

DJ

Lezen

10 dec 2025, 21:14 UTC

Winsten

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

DJ

Lezen

10 dec 2025, 21:14 UTC

Winsten

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

DJ

Lezen

Peer Vergelijking

Prijswijziging

Inovio Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

236.24% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 7.33 USD  236.24%

Hoogste 13 USD

Laagste 3 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor Inovio Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

3 ratings

2

Buy

1

Hold

0

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan Inovio Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

1.76 / 1.94Steun & Weerstand

Korte Termijn

Bullish Evidence

Recent bullish events outweigh bearish events.

Gemiddeld Termijn

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Lange Termijn

No Evidence

There are no events.

Sentiment

By Acuity

195 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

$

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,008.12

↑ +1.46%

JNJ

Johnson and Johnson

209.41

↑ +2.16%

ABBV

AbbVie Inc

222.68

↓-1.08%

UNH

UnitedHealth Group Inc

336.6

↑ +2.73%

AZN

AstraZeneca PLC ADR

90.64

↓-0.59%
help-icon Live chat